Mission Statement
“To unlock the full potential of protein science, delivering innovative, customized protein design and consultancy services that drive transformative results. We are committed to advancing the boundaries of scientific discovery and providing our clients with tailored solutions that meet their specific research and development goals. Through expertise, collaboration, and cutting-edge technology, we aim to contribute to a healthier, more sustainable future.”
Mark Bakkers
Co-Founder
A recognized expert in emerging viruses and known for his innovative approaches to vaccine design, Mark brings over 15 years of experience in academia and the pharmaceutical industry. With a background that bridges both research and application, he turns scientific insights into practical solutions. Specializing in the structural vaccinology of respiratory viruses, his expertise in high-throughput evaluations and assay development combined with a deep understanding of virology ensure a smooth transition from concept to clinical application.
As co-founder of ForgeBio, Mark is dedicated to advancing protein engineering and driving breakthroughs in vaccine design. His leadership is central to ForgeBio’s commitment to innovation and collaboration, positioning the company at the forefront of the fight against infectious diseases.
Hans Langedijk
Co-Founder
Known for cracking protein instability challenges for viral fusion proteins, Hans is a trailblazer in Structural Vaccinology, with over 100 peer-reviewed papers, and more than 40 patents in the field. His career spans more than three decades and covers academia, small biotech and big pharma. His deep knowledge of protein biochemistry and vaccine development ensures that innovative designs transform into real-world results.
As co-founder of ForgeBio, Hans is on a mission to redefine protein engineering by leveraging new technologies and fostering collaboration. His leadership is at the heart of ForgeBio’s drive to innovate and make a difference in healthcare